Announced Mon, 27 Jul · 15:35 IST
Q1 FY27 Results and SMP Appointment at Senores Pharmaceuticals
Management Changes View source PDF
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
—1-day move
₹1397.90
prior close
₹1408.30
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-6.5-6.1-7.4-5.3——————————
Up moveDown movePending
AI summary
Q1 FY27 consolidated revenue at Rs 180.2 cr, up 36% YoY. EBITDA rose 87% to Rs 54 cr; PAT up 56% at Rs 31 cr. Regulated markets revenue grew 42% YoY; emerging markets up 30%. Approved ANDAs doubled to 58. Board appointed Ms Anjali Shah, a Chartered Accountant with 10-plus years of finance experience, as AVP-Finance categorized as SMP. Of Rs 500 cr IPO proceeds, Rs 399.46 cr utilized till June 30, 2026.
Likely market impact
Strong broad-based quarterly growth and margin expansion; SMP addition is routine. Positive FY27 outlook reaffirmed by management.